http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2019014845-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37ed174d840a2d8b49bc84a3ff1df856
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
filingDate 2018-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_184929216e9f9a5782d07f5aee4b1c94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93752b6bb6470b2830eb7963c98134e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dcbc3a529269829d09affd29a8b0f55
publicationDate 2020-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2019014845-A
titleOfInvention AMINOTIAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS.
abstract Aminothiazole compounds of Formula (I) shown below and pharmaceutical compositions containing one such compound are described: (see Formula) Also described are methods of inhibiting a tyrosine kinase and treating cancer associated with a tyrosine kinase with one of the aminothiazole compounds.
priorityDate 2017-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518040

Total number of triples: 23.